CA Patent

CA3258471A1 — CRYSTALLINE FORM OF (S)-7-(l-ACRYLOYLPIPERIDIN-4-YL)-2-(4- PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[l,5-A]PYRIMIDINE-3- CARBOXAMIDE, PREPARATION, AND USES THEREOF

Assigned to BeOne Medicines I GmbH · Expires 2026-03-02 · 0y expired

What this patent protects

Patent listed against Brukinsa.

Drugs covered by this patent

Patent Metadata

Patent number
CA3258471A1
Jurisdiction
CA
Classification
—
Expires
2026-03-02
Drug substance claim
No
Drug product claim
No
Assignee
BeOne Medicines I GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.